Trademark: 88453270
Word
ACERTIS PHARMACEUTICALS
Status Date
Monday, February 10, 2020
Filing Date
Thursday, May 30, 2019
Published for Opposition
Tuesday, October 15, 2019
Abandoned Date
Monday, February 10, 2020
5 Pharmaceutical preparations for the prevention of endometrial hyperplasia and the management of exogenous obesity
The color(s) purple is/are claimed as a feature of the mark.
"PHARMACEUTICALS"
The mark consists of the purple stylized wordings "ACERTIS" above "PHARMACEUTICALS" all to the right of a triangle design displayed in various shades of purple and having a triangular center space. The white appearing in the mark represents background and is not claimed as a feature of the mark.
Feb 10, 2020
Abandonment Notice E-Mailed - After Publication
Feb 10, 2020
Abandonment - After Publication
Feb 5, 2020
Teas Express Abandonment Received
Nov 8, 2019
Extension Of Time To Oppose Received
Oct 15, 2019
Official Gazette Publication Confirmation E-Mailed
Oct 15, 2019
Published For Opposition
Sep 25, 2019
Notification Of Notice Of Publication E-Mailed
Sep 9, 2019
Assigned To Lie
Sep 5, 2019
Approved For Pub - Principal Register
Sep 4, 2019
Teas/Email Correspondence Entered
Sep 3, 2019
Correspondence Received In Law Office
Sep 3, 2019
Teas Response To Office Action Received
Aug 26, 2019
Notification Of Non-Final Action E-Mailed
Aug 26, 2019
Non-Final Action E-Mailed
Aug 26, 2019
Non-Final Action Written
Aug 20, 2019
Assigned To Examiner
Jun 15, 2019
Notice Of Design Search Code E-Mailed
Jun 14, 2019
New Application Office Supplied Data Entered In Tram
Jun 3, 2019
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
